CERo Therapeutics raises up to $7M via Series E convertible preferred private placement

CERO THERAPEUTICS HOLDINGS, INC.

Initial closing of ~$1.8M; Series E convertible at $1,000 stated value, conversion price $4.1625 per share.
Series C and D conversion price reduced to $1.76 as consent for pari passu treatment with Series E.
Company to seek stockholder approval by Oct 31, 2025 for lower conversion; meeting target Dec 31, 2025.
Bankruptcy trigger and company optional redemption each at 25% premium.
Registration rights agreement filed to register resale of conversion shares.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

CERO THERAPEUTICS HOLDINGS, INC. issued up to 9,750 shares of the Company's Series E convertible preferred stock of preferred stock to certain accredited investors named therein (the "PIPE Investors") for aggregate purchase price of up to $7 million.

Security: preferred stock
Shares: up to 9,750 shares of the Company's Series E convertible preferred stock
Purchaser: certain accredited investors named therein (the "PIPE Investors")
Consideration: aggregate purchase price of up to $7 million

Exact text from the filing

Pursuant to the Securities Purchase Agreement, up to 9,750 shares of the Company’s Series E convertible preferred stock, par value $0.0001 per share (the “ Series E Preferred Stock ”) shall be purchased for an aggregate purchase price of up to $7 million in one or more closings

View on SEC.gov

32 equity issuances filed in the last 30 days. Browse all equity issuances →

CERO THERAPEUTICS HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001213900-25-098421

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.